PhD Programme in Experimental Medicine and Therapy - Dottorato in Medicina e Terapia Sperimentale

1) E Bassino, S Fornero, MP Gallo, R Ramella, SK Mahata, B Tota, R Levi, G Alloatti (2011). A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K–eNOS pathway in the myocardium. CARDIOVASCULAR RESEARCH, vol. 91, p. 617-624, ISSN: 0008-6363, doi: 10.1093/cvr/cvr129

2) BASSINO E, FORNERO S, GALLO MP, LEVI R, TOTA B, MAHATA SK, ALLOATTI G (2011). Catestatin-induced cardioprotection involves a PI3K-Akt-GSK3ß pathway converging on mitochondrial membrane potential preservation. ACTA PHYSIOLOGICA, vol. 203 suppl 688, p. 179, ISSN: 1748-1708

BASSINO E, FORNERO S., GALLO MP, CRAVERO D, MAHATA SK, TOTA B, ALLOATTI G (2010). The anti-adrenergic effects exerted in rat ventricular myocardium by the Chromogranin A-derived peptide Catestatin variants are related to their anti-hypertensive potential. In: Atti 61° Congresso Nazionale SIF. Varese, 15-17/09/2010, Varese: Società Italiana di Fisiologia, p. 79-79

1) BASSINO E, FORNERO S., GALLO MP, LEVI R, TOTA B, MAHATA SK, ALLOATTI G (2011). Catestatin-induced cardioprotection involves a PI3K-Akt-GSK3ß pathway converging on the mithocondrial membrane potential preservation. In: Atti VII International Meeting on Chromogranin A and its derived peptides. Capri, 2011, Cosenza: University of Calabria, Italy, p. 21-21

2) BASSINO E, FORNERO S., GALLO MP, CRAVERO D, MAHATA SK, TOTA B, ALLOATTI G (2010). The anti-adrenergic effects exerted in rat ventricular myocardium by the Chromogranin A-derived peptide Catestatin variants are related to their anti-hypertensive potential. In: Atti 61° Congresso Nazionale SIF. Varese, 15-17/09/2010, Varese: Società Italiana di Fisiologia, p. 79-79